Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Items 501–600 of 1,004
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
Lee, D.-H., Jeong, Y. J., Won, J., Sim, H.-I., Park, Y., & Jin, H. (2022) · Biomedicines · doi:10.3390/biomedicines10020299 · Cited by 25
PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies
Chen, S., Paul, M. R., Sterner, C. J., Belka, G. K., Wang, D., Xu, P. J., Sreekumar, A., Pan, T.-C., Pant, D. K., Makhlin, I., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-022-01559-3 · Cited by 25
“Within the TCGA BRCA cohort [8], survival data and copy number calls from GISTIC2 were obtained from the NIH Genomic Data Commons (GDC) portal [27].”
MethodArtificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma
Knudsen, J. E., Rich, J. M., & Ma, R. (2023) · Urologic Clinics of North America · doi:10.1016/j.ucl.2023.06.002 · Cited by 25
Read, M. L., Brookes, K., Zha, L., Manivannan, S., Kim, J., Kocbiyik, M., Fletcher, A., Gorvin, C. M., Firth, G., Fruhwirth, G. O., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2043 · Cited by 25
CCPA: cloud-based, self-learning modules for consensus pathway analysis using GO, KEGG and Reactome
Nguyen, H., Pham, V.-D., Nguyen, H., Tran, B., Petereit, J., & Nguyen, T. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae222 · Cited by 25
“…over the past decades, leading to the establishment of multiple billion-dollar data repositories for biomedical research, such as the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) [16, 17], The Cancer Genome Atlas (GDC/TCGA) [18] and ArrayExpress [19, 20].”
OpenGDC: Unifying, Modeling, Integrating Cancer Genomic Data and Clinical Metadata
Cappelli, E., Cumbo, F., Bernasconi, A., Canakoglu, A., Ceri, S., Masseroli, M., & Weitschek, E. (2020) · Applied Sciences · doi:10.3390/app10186367 · Cited by 25
Rayner, J. E., Duffy, D. L., Smit, D. J., Jagirdar, K., Lee, K., De’Ambrosis, B., Smithers, B. M., McMeniman, E., McInerney-Leo, A. M., Schaider, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238529 · Cited by 25
“We sourced a secondary data set of germline and somatic DNA sequence from the NIH National Cancer Institute Genomic Data Commons Data Portal, The Cancer Genome Atlas (TCGA) program consisting of whole genome sequence from 10,389 cancer patients which included 470 melanoma cases [34].”
Budginaite, E., Morkūnas, M., Laurinavičius, A., & Treigys, P. (2021) · Informatica · doi:10.15388/20-infor442 · Cited by 25
SK4 oncochannels regulate calcium entry and promote cell migration in KRAS-mutated colorectal cancer
Ibrahim, S., Chaigne, J., Dakik, H., Fourbon, Y., Corset, L., Lecomte, T., Raoul, W., & Guéguinou, M. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102384 · Cited by 25
Parzefall, T., Schnoell, J., Monschein, L., Foki, E., Liu, D. T., Frohne, A., Grasl, S., Pammer, J., Lucas, T., Kadletz, L., et al. (2021) · Cancers · doi:10.3390/cancers13092082 · Cited by 25
“Datasets containing RNA-Seq (RSEM) results were retrieved through the National Cancer Institute (NCI) Genomic Data Commons (GDC) Application Programming Interface (API) with the R/Bioconductor package TCGAbiolinks [33,34].”
MethodReview of diffusion models and its applications in biomedical informatics
Luo, J., Yang, L., Liu, Y., Hu, C., Wang, G., Yang, Y. C., Yang, T.-L., & Zhou, X. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03210-5 · Cited by 24
“Experimental results on The Cancer Genome Atlas (TCGA) dataset [41] showed that the proposed method outperformed GAN-based methods [42].”
An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a
Serviss, J. T., Andrews, N., den Eynden, J. V., Richter, F. C., Houtman, M., Vesterlund, M., Schwarzmueller, L., Johnsson, P., Larsson, E., Grandér, D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0777-5 · Cited by 24
The genomic loci of specific human tRNA genes exhibit ageing-related DNA hypermethylation
Acton, R., Yuan, W., Gao, F., Xia, Y., Bourne, E., Wozniak, E., Bell, J. T., Lillycrop, K. A., Wang, J., Dennison, E. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22639-6 · Cited by 24
“Data was downloaded from the TCGA (The Cancer Genome Atlas) via the GDC (genomic data commons) data 494 portal [119] using the GenomicDataCommons R package.”
MethodGujar, H., Mehta, A., Li, H., Tsai, Y., Qiu, X., Weisenberger, D. J., Jasiulionis, M. G., In, G. K., & Liang, G. (2021) · Genome Medicine · doi:10.1186/s13073-021-00946-3 · Cited by 24
“GDC for prostate cancer DNA methylation data [114].”
Backgroundde Vos, L., Cano, T. M. C., Zarbl, R., Klümper, N., Ralser, D. J., Franzen, A., Herr, E., Gabrielpillai, J., Vogt, T. J., Dietrich, J., et al. (2022) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000429 · Cited by 24
Robertis, M. D., Greco, M. R., Cardone, R. A., Mazza, T., Marzano, F., Mehterov, N. H., Kazakova, M., Belev, N., Tullo, A., Pesole, G., et al. (2022) · Cells · doi:10.3390/cells11223568 · Cited by 24
Case Studies for Overcoming Challenges in Using Big Data in Cancer
Sweeney, S. M., Hamadeh, H. K., Abrams, N., Adam, S. J., Brenner, S., Connors, D. E., Davis, G. J., Fiore, L. D., Gawel, S. H., Grossman, R. L., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1277 · Cited by 24
Self-citationTierno, D., Grassi, G., Zanconati, F., Bortul, M., & Scaggiante, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021799 · Cited by 24
Song, X., Ji, J., Rothstein, J. H., Alexeeff, S., Sakoda, L. C., Sistig, A., Achacoso, N. S., Jorgenson, E., Whittemore, A. S., Klein, R. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35888-4 · Cited by 24
“We evaluated the prediction performance of MiXcan in an independent dataset of 103 European ancestry female breast cancer patients with adjacent normal tissue samples from TCGA 63,64 .”
MethodModeling double strand break susceptibility to interrogate structural variation in cancer
Ballinger, T. J., Bouwman, B. A. M., Mirzazadeh, R., Garnerone, S., Crosetto, N., & Semple, C. A. M. (2019) · Genome biology · doi:10.1186/s13059-019-1635-1 · Cited by 24
Cardioinformatics: the nexus of bioinformatics and precision cardiology
Khomtchouk, B. B., Tran, D.-T. T., Vand, K. A., Might, M., Gozani, O., & Assimes, T. L. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz119 · Cited by 24
“Other major players in the cancer knowledge base arena include the National Cancer Institute’s Genomic Data Commons (GDC) Portal [26, 27], which provides full download and access to all raw data (e.g. mRNA expression files, full segmented copy number variant [CNV] files, etc.) generated by TCGA and…”
BackgroundBusso-Lopes, A. F., Carnielli, C. M., Winck, F. V., Patroni, F. M. D. S., Oliveira, A. K., Granato, D. C., Costa, R. A. P. E., Domingues, R. R., Pauletti, B. A., Riaño‐Pachón, D. M., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100118 · Cited by 24
“gov) for oral and other cancer types (43, 44).”
BackgroundResearch Infrastructure for the Safe Analysis of Sensitive Data
Foster, I. T. (2017) · The Annals of the American Academy of Political and Social Science · doi:10.1177/0002716217742610 · Cited by 24
Informatics for cancer immunotherapy
Hammerbacher, J., & Snyder, A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx682 · Cited by 24
“The Genomic Data Commons [28] makes available single-nucleotide variant and short insertion and deletion (indel) calls from MuTect2, SomaticSniper [29], VarScan2 [30], and MuSE [31].”
BackgroundecTMB: a robust method to estimate and classify tumor mutational burden
Yao, L., Fu, Y., Mohiyuddin, M., & Lam, H. Y. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-61575-1 · Cited by 24
Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells
Doubleday, P. F., Fornelli, L., Ntai, I., & Kelleher, N. L. (2021) · The FEBS Journal · doi:10.1111/febs.16111 · Cited by 23
AI for scientific discovery is a social problem
Channing, G., & Ghosh, A. (2026) · Patterns · doi:10.1016/j.patter.2026.101497 · Cited by 23
“35,64,89 The FAIR principles (findable, accessible, interoperable, and reusable) are being increasingly applied not only to data but also to AI models and software, although their implementation remains challenging and requires community consensus.”
Papaleo, E., Gromova, I., & Gromov, P. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1387053 · Cited by 23
“Inspiration in this direction can come fromgenomic initiatives such as the Genomics Data Commons portal [130] where data collected from different teams and consortia on different cancer studies have been deposited together.”
BackgroundSong, J., Zhou, Y., Yakymovych, I., Schmidt, A., Li, C., Heldin, C., & Landström, M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104155 · Cited by 23
Pilo, C. A., Baffi, T. R., Kornev, A. P., Kunkel, M. T., Malfavon, M., Chen, D.-H., Rossitto, L.-A. M., Chen, D. X., Huang, L., Longman, C., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abk1147 · Cited by 23
“S4A) (53), and the total mutation frequency within each domain (number of mutations per residue in the domain) was analyzed (fig.”
BackgroundGlycoEnzOnto: a GlycoEnzyme pathway and molecular function ontology
Groth, T., Diehl, A. D., Gunawan, R., & Neelamegham, S. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac704 · Cited by 23
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Faget, D. V., Luo, X., Inkman, M. J., Ren, Q., Su, X., Ding, K., Waters, M. R., Raut, G. K., Pandey, G., Dodhiawala, P. B., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0907 · Cited by 24
Sobral, P., Luz, V. C. C., Almeida, J. M. G. C. F., Videira, P. A., & Pereira, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065908 · Cited by 24
Mapping the functional interactions at the tumor-immune checkpoint interface
Bozorgui, B., Kong, E., Luna, A., & Korkut, A. (2023) · Communications Biology · doi:10.1038/s42003-023-04777-3 · Cited by 23
“…types that may have differential impact on immune regulation as well as immune cell in fi ltration (leukocyte fraction) 19 , tumor mutation burden 20 , epithelial-mesenchymal transition (EMT) status 21 , vascularization 22 , T-cell in fl ammation signature 23 , and IFN γ expression 16…”
Cell Graph Transformer for Nuclei Classification
Lou, W., Li, G., Wan, X., & Li, H. (2024) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v38i4.28179 · Cited by 24
APOBEC affects tumor evolution and age at onset of lung cancer in smokers
Zhang, T., Sang, J., Hoang, P. H., Wei, Z., Rosenbaum, J., Johnson, K. E., Klimczak, L. J., McElderry, J. P., Klein, A., Wirth, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59923-8 · Cited by 23
“Additionally, we collected clinical and exposure information from the GDC Data Portal.”
InfluentialProgress Toward Cancer Data Ecosystems
Grossman, R. L. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000318 · Cited by 23
Self-citationKim, H. J., Kim, H. J., Park, Y., Lee, W. S., Lim, Y., & Kim, J. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-58088-2 · Cited by 23
MAL2-Induced Actin-Based Protrusion Formation is Anti-Oncogenic in Hepatocellular Carcinoma
López-Coral, A., Vecchio, G., Chahine, J. J., Kallakury, B., & Tuma, P. L. (2020) · Cancers · doi:10.3390/cancers12020422 · Cited by 23
“However, results from the NCI Genomic Data Commons (GDC) [30] indicate that no such MAL2 mutations have been observed in almost 8000 patients representing 18 different cancer types (Figure 11).”
BackgroundTargeting Human Lung Adenocarcinoma with a Suppressor of Mitochondrial Superoxide Production
Amoêdo, N. D., Dard, L., Sarlak, S., Mahfouf, W., Blanchard, W., Rousseau, B., Izotte, J., Claverol, S., Lacombe, D., Rezvani, H. R., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7892 · Cited by 24
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data
Geles, K., Palumbo, D., Sellitto, A., Giurato, G., Cianflone, E., Marino, F., Torella, D., Cappa, V. M., Nassa, G., Tarallo, R., et al. (2021) · F1000Research · doi:10.12688/f1000research.27868.3 · Cited by 15
Müller, M., Burmeister, A., Skowron, M. A., Stephan, A., Bremmer, F., Wakileh, G. A., Petzsch, P., Köhrer, K., Albers, P., & Nettersheim, D. (2022) · Clinical Epigenetics · doi:10.1186/s13148-021-01223-1 · Cited by 23
“Next, gene expression and mutation profiles of the targets of the eight epi-drugs with highest efficiency (Quisinostat, JIB-04, PBIT, Chaetocin, MZ-1, LP99, PRT4165, GSK343) were analyzed by screening the ’Testicular Germ Cell Tumors’ cohort of ‘The Cancer Genome Atlas’ (TCGA [8, 42, 43]) using cBioPortal [44, 45] (Fi…”
MethodOverexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
Bose, M., Grover, P., Sanders, A. J., Zhou, R., Ahmad, M., Shwartz, S., Lala, P., Nath, S., Yazdanifar, M., Brouwer, C., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.821875 · Cited by 23
“Twenty-nine pancreatic adenocarcinoma tumor RNA-Seq data were downloaded from the Genomic Data Commons data portal (Grossman et al., 2016).”
MethodYang, M., Davis, T. B., Pflieger, L., Nebozhyn, M. V., Loboda, A., Wang, H., Schell, M. J., Thota, R., Pledger, W. J., & Yeatman, T. J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09344-3 · Cited by 22
“by two independent CRC tumor datasets We validated the findings from > 2000 Moffitt CRC tumors using two independent, publicly-available CRC human datasets (Marisa 585 CRCs [23] and TCGA 677 CRCs [47], see METHODS).”
MethodInsights into the structural and functional activities of forgotten Kinases: PCTAIREs CDKs
Karimbayli, J., Pellarin, I., Belletti, B., & Baldassarre, G. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02043-6 · Cited by 22
“TCGA mutation data was retrieved from GDC database [154].”
MethodCytogenetic signatures favoring metastatic organotropism in colorectal cancer
Golas, M. M., Gunawan, B., Gutenberg, A., Danner, B. C., Gerdes, J. S., Stadelmann, C., FÜZESI, L., Liersch, T., & Sander, B. O. (2025) · Nature Communications · doi:10.1038/s41467-025-58413-1 · Cited by 22
“Differential gene expression analysis was analyzed using two-sided Wilcoxon rank-sumtests with Benjamini-Hochbergadjustment 116 to compare the following CRC groups: (I) KRAS mutation and ampli fi cation; (II) KRAS mutation; (III) KRAS wildtype; (IV) KRAS deletion (but no oncogenic mutation); (V) MLH1 del: MLH1 deletion…”
InfluentialFinding cancer driver mutations in the era of big data research
Poulos, R. C., & Wong, J. W. H. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0415-6 · Cited by 23
Functional analysis of RPS27 mutations and expression in melanoma
Floristán, A., Morales, L. J., Hanniford, D., Martinez, C. N., Castellano‐Sanz, E., Dolgalev, I., Ulloa-Morales, A. J., de Miera, E. V., Moran, U., Darvishian, F., et al. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12841 · Cited by 22
“TCGA data Somatic mutation data from 403 matched tumor–normal samples from The Cancer Genome Atlas Skin Cutaneous Melanoma Whole Exome Sequencing dataset (TCGA SKCM WES) were retrieved in Mutation Annotation Format (MAF) using the Genomic Data Commons (GDC) portal (Grossman et al., 2016).”
MethodPrevalence, causes and impact of TP53-loss phenocopying events in human tumors
Fito-Lopez, B., Salvadores, M., Álvarez‐Álvarez, M. M., & Supek, F. (2023) · BMC Biology · doi:10.1186/s12915-023-01595-1 · Cited by 22
“We collected CNA from GDC Data Portal (74) for TCGA samples and from DepMap (64) for CL samples.”
MethodInfluentialHoffman, T. E., Nangia, V., Ill, C. R., Passanisi, V. J., Armstrong, C., Yang, C., & Spencer, S. L. (2023) · Science Signaling · doi:10.1126/scisignal.ade8744 · Cited by 22
Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma
Gotoh, O., Sugiyama, Y., Tonooka, A., Kosugi, M., Kitaura, S., Minegishi, R., Sano, M., Amino, S., Furuya, R., Tanaka, N., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6278 · Cited by 22
“We show heatmaps for NAEH/AEH samples that were collected in the current cohort, as well as those for NE and EEC samples, data for which were obtained from the TCGA database [15].”
MethodBaul, S., Ahmed, K. T., Jiang, Q., Wang, G., Li, Q., Yong, J., & Zhang, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae316 · Cited by 22
“The WSIs for the TCGA BRCA data were obtained from the Genomic Data Commons Data Portal [56].”
Binato, R., dos Santos, E. C., Boroni, M., Demachki, S., de Assumpção, P. P., & Abdelhay, E. S. F. W. (2017) · Oncotarget · doi:10.18632/oncotarget.23670 · Cited by 22
“Public available RNA-Seq and clinical data from 158 intestinal-type gastric cancer and 15 normal tissues samples from The Cancer Genome Atlas (TCGA) project was downloaded from the NCI’s Genomic Data Commons (GDC) [66] using CGAbiolinks Bioconductor R package [67].”
MethodGenome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors
Singh, B., Trincado, J. L., Tatlow, P., Piccolo, S., & Eyras, E. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0601 · Cited by 22
ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification
Schneider, L., Kehl, T., Thedinga, K., Grammes, N., Backes, C., Mohr, C., Schubert, B., Lenhof, K., Gerstner, N., Hartkopf, A., et al. (2019) · Bioinform. · doi:10.1093/bioinformatics/btz302 · Cited by 18
Volkmann, A., Bin, R. D., Sauerbrei, W., & Boulesteix, A. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0802-0 · Cited by 22
Jin, Y., Byun, S., Han, S., Chamberlin, J., Kim, D., Kim, M. J., & Lee, Y. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0635-z · Cited by 22
Peris-Torres, C., Plaza‐Calonge, M. D. C., López-Domínguez, R., Domínguez-García, S., Barrientos‐Durán, A., Carmona‐Sáez, P., & Rodríguez-Manzaneque, J. C. (2020) · Cancers · doi:10.3390/cancers12040801 · Cited by 22
“Considering the infrequent nature of this tumor, the public availability of gene expression data in the TCGA-UVM Project [28] allowed us to pursue such analyses in a relevant number of samples, including prognosis parameters and staging classification.”
MethodShrestha, S., Katiyar, S., Sanz-Rodríguez, C. E., Kemppinen, N. R., Kim, H. W., Kadirvelraj, R., Panagos, C. G., Keyhaninejad, N., Colonna, M. B., Chopra, P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax6313 · Cited by 22
“Expression analysis Human tumor expression data were obtained from the National Cancer Institute’s Genomic Data Commons Data Portal (downloaded 10 February 2017) (70).”
MethodHuang, J., Emran, A. A., Endaya, J. M., McCaughan, G. W., Gorrell, M. D., & Zhang, H. E. (2021) · Cancers · doi:10.3390/cancers13071637 · Cited by 22
“gov/ 20 April 2020 [35] Catalogue of Somatic Mutation in Cancer (COSMIC) https://cancer.”
BackgroundAdvances in Adoptive Cell Therapy for Head and Neck Cancer
Norberg, S. M., & Hinrichs, C. S. (2021) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.05.001 · Cited by 22
“Expression is thought to be restricted to immuneprivileged sites and has been found to be expressed in head and neck cancer.(35,36) A clinical trial is testing this TCR in patients with multiple different cancers including head and neck (NCT03132922).”
BackgroundA Precision Diagnostic Framework of Renal Cell Carcinoma on Whole-Slide Images using Deep Learning
Wu, J., Zhang, R., Gong, T., Bao, X., Gao, Z., Zhang, H., Wang, C., & Li, C. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669870 · Cited by 22
Performance Comparisons of AlexNet and GoogLeNet in Cell Growth Inhibition IC50 Prediction
Lee, Y., & Nam, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147721 · Cited by 22
“In the model construction, training data sources included Connectivity Map (CMap) [32], the Cancer Cell Line Encyclopedia (CCLE) [33], Genomics in Drug Sensitivity in Cancer (GDSC) [34], the Catalogue of Somatic Mutations in Cancer (COSMIC) [35], and the Genomic Data Commons Data Portal (GDC) [36].”
MethodInfluentialMittra, S., Harding, S. M., & Kaech, S. M. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300049 · Cited by 21
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
Wamsley, N. T., Wilkerson, E., Guan, L., LaPak, K. M., Schrank, T. P., Holmes, B., Sprung, R. W., Erdmann-Gilmore, P., Gerndt, S. P., Jackson, R. S., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100647 · Cited by 21
“This article contains supplemental data (45, 46, 51, 75 – 77).”
BackgroundGarcía-Cárdenas, J. M., Indacochea, A., Pesantez-Coronel, D., Terán-Navas, M., Aleaga, A., Armendáriz‐Castillo, I., Zúñiga, L. P., Morán-Erazo, C., Chávez-Vélez, E., Pérez‐Villa, A., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00398 · Cited by 22
“These data sets included ethnicity records from well-known initiatives such as TCGA, 1 TARGET, 2,3 International Cancer Genome Consortium (ICGC), 31 and Prostate Cancer Foundation Dream Team, 32,33 among others.”
NIAGADS: A data repository for Alzheimer's disease and related dementia genomics
Kuzma, A. B., Valladares, O., Greenfest‐Allen, E., Nicaretta, H. I., Kirsch, M., Ren, Y., Katanić, Ž., White, H., Wilk, A. J., Bass, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70255 · Cited by 21
Thompson, J. A., Christensen, B. C., & Marsit, C. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082296 · Cited by 21
“Data for fourteen cancer types were obtained from the National Cancer Institute’s Genomic Data Commons Data Portal Legacy Archive [28] (Table 1).”
MethodHur, J. Y., Kim, H. R., Lee, J. Y., Park, S., Hwang, J. A., Kim, W. S., Yoon, S., Choi, C., Rho, J. K., & Lee, J. C. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00434-2 · Cited by 21
Höllbacher, B., Balázs, K., Heinig, M., & Uhlenhaut, N. H. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.05.018 · Cited by 21
“Within the cancer research field, the Cancer Genome Atlas [11] offers a vast collection of genetic, epigenetic, transcriptional and proteomics data on 33 different cancer types, which can be accessed through the Genomic Data Commons Data Portal [12].”
Wang, X. Q., Wang, X. Q., Hsu, A. T. Y. W., Goytain, A., Ng, T., & Nielsen, T. O. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.11.011 · Cited by 21
Koşaloğlu‐Yalçın, Z., Blazeska, N., Carter, H. K., Nielsen, M., Cohen, E. E. W., Kufe, D. W., Conejo-Garcia, J. R., Robbins, P. F., Schoenberger, S. P., Peters, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.735609 · Cited by 21
“For example, based on the tumor type, the expression level of different source antigens can be estimated using National Cancer Institute (NCI) databases such as cBioPortal (19, 42) and the GDC Data Portal (43), even if that expression data is not speci fi cally measured in the original experiments.”
MethodBhattarai, S., Sugita, B. M., Bortoletto, S., Fonseca, A. S., Cavalli, L. R., & Aneja, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111548 · Cited by 21
“The expression levels of CA20 and CIN25 signature genes and annotated clinicopathological data were obtained from the TCGA breast cancer dataset through the TCGA Genomic Data Commons (GDA) Data Portal [84].”
MethodBelltall, A., Zúñiga, S., Garrido‐Cano, I., Eroles, P., Argente-Navarro, M. P., Buggy, D. J., Díaz‐Cambronero, Ó., & Mazzinari, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.801411 · Cited by 21
“The TCGA is a National Institute of Health (NIH) sponsored project that aims to discover significant cancer-causing genome alterations in large cohorts of tumors through large-scale genome sequencing (25, 26).”
BackgroundLepski, G. A., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., Flatow, E. A., de Oliveira, J. V., Fogolin, C., Peres, N., et al. (2023) · Cancers · doi:10.3390/cancers15041239 · Cited by 21
Sarfaty, M., Golkaram, M., Funt, S. A., Al‐Ahmadie, H. A., Kaplan, S., Song, F., Regazzi, A. M., Makarov, V., Kuo, F., Ostrovnaya, I., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02144 · Cited by 21
G-quadruplex-mediated genomic instability drives SNVs in cancer
Richl, T., Kuper, J., & Kisker, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae098 · Cited by 20
Predicting Nottingham grade in breast cancer digital pathology using a foundation model
Kim, J. S., Lee, J. H., Yeon, Y., An, D., Kim, S. J., Noh, M., & Lee, S. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02019-4 · Cited by 20
Li, X., Wu, Y., Guo, J., Huang, P., Li, Q., Gao, Z., Hu, Y., Gao, A., Sun, M., Min, H., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07922-4 · Cited by 20
“For replication, the aberrant activation of TRIM31 were further con fi rmed by Wilcoxon test-based comparison of expression of TRIM31 in large (with over 100 patients) CRC cohorts (TCGA-COAD [27], TCGA-READ [27], CPTAC2-Colon [28]) from GDC [29] versus normal colon tissue samples from GTEx [30].”
Reliable detection of Host-Microbe Signatures in cancer using PRISM
Ghaddar, B., Blaser, M. J., & De, S. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.007 · Cited by 20
Fauteux, F., Surendra, A., McComb, S., Pan, Y., & Hill, J. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-88209-4 · Cited by 20
Zhou, S., Sun, Y., Chen, T., Wang, J., He, J., Lyu, J., Shen, Y., Chen, X., & Yang, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739594 · Cited by 20
Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types
Zeng, Y., Lin, D., Gao, M., Du, G., & Cai, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05987-1 · Cited by 20
García-Prieto, C. A., Martínez-Jiménez, F., Valencia, A., & Porta‐Pardo, E. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btac306 · Cited by 20
Sambruni, G., Macandog, A. D. G., Wirbel, J., Cagnina, D., Catozzi, C., Dallavilla, T., Borgo, F., Fazio, N., Romario, U. F., Petz, W. L., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01180-9 · Cited by 20
“by different sample preparations, we only considered samples analysed by the Illumina Truseq method (in COAD, LUAD and BRCA) and AllPrep RNA extraction (in OV) and removed the cases with duplicated samples (GBM and LUSC); the information about the preparation steps was downloaded from the GDC Legacy Archive [38].”
MethodLeng, J., Xu, H., Liu, X., Yang, Y., Ning, C., Sun, L., Qu, J., Ke, X., & Lan, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01320-6 · Cited by 20
“We downloaded all the pancreatic ductal adenocarcinoma RNA-seq data from TCGA database using the officially recommended gdc-client software (version 1.2.0) [18] in a bam format.”
MethodInfluentialAntagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy
Liang, B., Xing, X., Storts, H., Ye, Z., Claybon, H., Austin, R., Ding, R., Liu, B., Wen, H., Miles, W. O., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1441935 · Cited by 20
Inferring single-cell and spatial microRNA activity from transcriptomics data
Herbst, E., Mandel‐Gutfreund, Y., Yakhini, Z., & Biran, H. (2025) · Communications Biology · doi:10.1038/s42003-025-07454-9 · Cited by 20
“We investigate the relationship between miTEA-HiRes activity p -values and measured expression by using data from the GDC portal 106 , which includes cancer tumors with matched bulk RNAseq and bulk miRNAseq samples.”
PanCanSurvPlot: A large-scale pan-cancer survival analysis web application
Lin, A., Yang, H., Shi, Y., Li, K., Chen, L., Wong, H. Z. H., Zhang, L., & Luo, P. (2025) · Current Proteomics · doi:10.1016/j.curpro.2025.100062 · Cited by 20
MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma
Wilkins, O. M., Titus, A., Salas, L. A., Gui, J., Eliot, M., Butler, R. A., Sturgis, E. M., Li, G., Kelsey, K. T., & Christensen, B. C. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0002 · Cited by 21
TCGAbiolinksGUI: A graphical user interface to analyze cancer molecular and clinical data
Silva, T. C., Colaprico, A., Olsen, C., Malta, T. M., Bontempi, G., Ceccarelli, M., Berman, B. P., & Noushmehr, H. (2018) · F1000Research · doi:10.12688/f1000research.14197.1 · Cited by 20
Pritchard, J., Hamilton, G. M., Hurst, C. D., Fraser, S., Orange, C., Knowles, M. A., Jones, R. J., Leung, H. Y., & Iwata, T. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.05.012 · Cited by 20
Perspectives of using Cloud computing in integrative analysis of multi-omics data
Augustyn, D. R., Wyciślik, Ł., & Mrozek, D. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab007 · Cited by 20
“Users can upload their own omics spreadsheets or access TCGA data (provided by The Cancer Genome Atlas (TCGA) program [17]).”
MethodRP11-616M22.7 recapitulates imatinib resistance in gastrointestinal stromal tumor
Shao, Y., Lian, S., Zheng, J., Tong, H., Wang, J., Xu, J., Liu, W., Hu, G., Zhang, Y., & He, J. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.017 · Cited by 20
Computational biologists: moving to the driver's seat
Yanai, I., & Chmielnicki, E. (2017) · Genome biology · doi:10.1186/s13059-017-1357-1 · Cited by 20
“Large databases are proliferating with myriad types of biological data, such as the Genomic Data Commons platform, which provides researchers access to genomic and clinical data from patients with cancer [4].”
BackgroundSouth Korea: in the midst of a privacy reform centered on data sharing
Kim, H., Kim, S. Y., & Joly, Y. (2018) · Human Genetics · doi:10.1007/s00439-018-1920-1 · Cited by 20
Kobren, S. N., & Singh, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1224 · Cited by 20
“We also downloaded all open-access TCGA somatic SNV data and RNA-seq expression data from NCI’s Genomic Data Commons on 15 July 2017 (36,37).”
MethodBoso, G., Fleck, K., Carley, S., Liu, Q., Buckler-White, A. J., & Kozak, C. A. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab245 · Cited by 20
Zubair, M., Khan, A. H., Bilal, S. F., & Li, J. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf541 · Cited by 19
“• Research methodology: assessment of review methods, limitations, and the importance of multi-omics data integr ation for a comprehensive understanding of cancer genomics [11 , 12].”
Ma, C., Li, C., Ma, H., Yu, D., Zhang, Y., Zhang, D., Su, T., Wu, J., Wang, X., Zhang, L., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02821-9 · Cited by 20
“Specifically, we retrieved paired-end RNA-seq data from the Genomic Data Commons (GDC) data portal [120] to increase the chance of unique mapping and thus the accuracy of paralog quantification.”
Method
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.